NIH precision medicine initiative: Implications for diabetes research

Diabetes Care

Volumn 39, Issue 7, 2016, Pages 1080-1084

  Fradkin, Judith E ^a   Hanlon, Mary C ^a   Rodgers, Griffin P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

AUTOIMMUNITY; CONFERENCE PAPER; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT PARTICIPATION; PERSONALIZED MEDICINE; PRECISION MEDICINE INITIATIVE; NATIONAL HEALTH ORGANIZATION; NEOPLASMS; ORGANIZATION AND MANAGEMENT; TRENDS; UNITED STATES;

BIOMEDICAL RESEARCH; DIABETES MELLITUS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; PRECISION MEDICINE; UNITED STATES;

EID: 84975815574     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0541     Document Type: Conference Paper

References (20)

1. American Diabetes Association. Standards of Medical Care in Diabetesd2016. Diabetes Care 2016;39(Suppl.):S1-S112
2. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372: 793-795
3. Precision Medicine Initiative Working Group to the Advisory Committee to the Director, NIH. The Precision Medicine Cohort Programd Building a Research Foundation for 21st Century Medicine, 2015. Available from https://www.nih.gov/sites/default/files/research-training/initiatives/pmi/pmi-working-group-report-20150917-2.pdf. Accessed 11 March 2016
4. RFA-PM-16-004: Precision Medicine Initiative Cohort Program Biobank (U24). Available from http://grants.nih.gov/grants/guide/rfa-files/RFA-PM-16-004.html. Accessed 11 March 2016
5. RFA-PM-16-001: Precision Medicine Initiative Cohort Program Coordinating Center (U2C). Available from http://grants.nih.gov/grants/guide/rfa-files/RFA-PM-16-001.html. Accessed 11 March 2016
6. RFA-PM-16-002: Precision Medicine Initiative Cohort Program Healthcare Provider Organization Enrollment Centers (UG3/UH3). Available from http://grants.nih.gov/grants/guide/rfa-files/RFA-PM-16-002.html. Accessed 11 March 2016
7. RFA-PM-16-003: Precision Medicine Initiative Cohort Program Participant Technologies Center (U24). Available from http://grants.nih.gov/grants/guide/rfa-files/RFA-PM-16-003.html. Accessed 11 March 2016
8. Prasad RB, Groop L. Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel) 2015;6:87-123
9. Hagopian WA, Erlich H, Lernmark A, et al.; TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011;12:733-743
10. Liu E, Lee HS, Aronsson CA, et al.; TEDDY Study Group. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014;371:42-49
11. Lee CC, Watkins SM, Lorenzo C, et al. Branched-chain amino acids and insulin metabolism: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care. 19 February 2016 [Epub ahead of print]
12. Nathan DM, Buse JB, Kahn SE, et al.; GRADE Study Research Group. Rationale and design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 2013;36:2254-2261
13. Jablonski KA, McAteer JB, de Bakker PI, et al.; Diabetes Prevention Program Research Group. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the Diabetes Prevention Program. Diabetes 2010;59:2672-2681
14. Soccio RE, Chen ER, Rajapurkar SR, et al. Genetic variation determines PPARg function and anti-diabetic drug response in vivo. Cell 2015;162:33-44
15. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 2014; 383:1084-1094
16. Klingensmith GJ, Pyle L, Arslanian S, et al.; TODAY Study Group. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010;33:1970-1975
17. Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2015;22:277-282
18. Li L, Cheng WY, Glicksberg BS, et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 2015;7:311ra174
19. PAR-15-182: Interdisciplinary Training in Bioinformatics and Diabetes, Obesity and Metabolic Disease (T32). Available from http://grants.nih.gov/grants/guide/pa-files/PAR-15-182.html. Accessed 11 March 2016
20. PAR-16-103: Institutional Research and Academic Career Development Awards (IRACDA) (K12). Available from http://grants.nih.gov/grants/guide/pa-files/PAR-16-103.html. Accessed 11 March 2016